Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Smoot

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Surgery|December 26, 2017
Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 millionChristopher R Shubert, Michael L Kendrick, Elizabeth B Habermann, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Surgical Oncology|July 22, 2016
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysisJohn R Bergquist, Tommy Ivanics, Curtis B Storlie, et al.
JHEP Reports : Innovation in Hepatology|March 23, 2023
Transcriptomic landscapes of effective and failed liver regeneration in humansPatrick Starlinger, Laura Brunnthaler, Chantal McCabe, et al.
European Journal of Human Genetics : EJHG|February 15, 2001
Elastin: mutational spectrum in supravalvular aortic stenosisK Metcalfe, A K Rucka, L Smoot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2025
Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: A single center retrospective analysisMarkus Ammann, Hallbera Gudmundsdottir, Stella K Adjei Antwi, et al.
FEBS Open Bio|September 19, 2024
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escapeRoberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Surgery|December 26, 2017
Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 millionChristopher R Shubert, Michael L Kendrick, Elizabeth B Habermann, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Surgical Oncology|July 22, 2016
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysisJohn R Bergquist, Tommy Ivanics, Curtis B Storlie, et al.
JHEP Reports : Innovation in Hepatology|March 23, 2023
Transcriptomic landscapes of effective and failed liver regeneration in humansPatrick Starlinger, Laura Brunnthaler, Chantal McCabe, et al.
European Journal of Human Genetics : EJHG|February 15, 2001
Elastin: mutational spectrum in supravalvular aortic stenosisK Metcalfe, A K Rucka, L Smoot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2025
Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: A single center retrospective analysisMarkus Ammann, Hallbera Gudmundsdottir, Stella K Adjei Antwi, et al.
FEBS Open Bio|September 19, 2024
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escapeRoberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, et al.
Pageof 18